Search Results 1081-1090 of 19932 for Receptor

  1. Women's Wellness: Vaginal atrophy after breast cancer - Mayo Clinic News Network

    This is particularly true if you've had a hormone dependent (estrogen and progesterone receptor positive) cancer. These options include: Vaginal ...

  2. Study in Pediatrics with HypEREosinophilic Syndrome - Mayo Clinic

    Platelet-derived Growth Factor Receptor (PDGFRα) (F/P)] positivity. Clinical diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA). Participants ...

  3. Publications - Shannon P. Fortin Ensign, M.D., Ph.D. - Mayo Clinic

    The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity. Mol ...

  4. SYMPHONY: A Study Of Macitentan In Pulmonary Arterial Hypertension To Validate The PAH-SYMPACT - Mayo Clinic

    Treatment with endothelin receptor antagonists (ERAs) within 3 months prior to Visit 2, or scheduled to receive any of these compounds, other than macitentan, ...

  5. Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer - Mayo Clinic

    Exceptions: Individuals who use prescription PPIs and have approval from their primary health care provider to replace the PPI with an H2 receptor agonist ...

  6. Reactive hypoglycemia: What causes it? - Mayo Clinic

    Alcohol: Does it affect blood pressure? Alpha blockers · Amputation and diabetes: How to protect your feet · Angiotensin II receptor blockers · Angiotensin- ...

  7. Publications - Paschalis Vergidis, M.D., M.S. - Mayo Clinic

    ... Receptor T Cell Therapy. Transplant Cell Ther. 2024 Apr; 30 (4):455.e1-455.e7 Epub 2024 Feb 10. View PubMed; Walker J, McCarty T, McGwin G, Ordaya EE ...

  8. Mayo Clinic Q&A podcast: Clinical trial for ductal carcinoma in situ vaccine

    ... receptor," says Dr. Amy Degnim, a surgeon with the Mayo Clinic Cancer Center. "HER2 is a protein that in some cases is on the outside of cancer cells and ...

  9. A Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients With Advanced or Metastatic Renal Cell Carcinoma - Mayo Clinic

    ... receptor (VEGFR) (e.g., sunitinib, pazopanib, sorafenib, tivozanib, cabozantinib). One prior immunotherapy (interleukin-2 or interferon-alpha or immune ...

  10. Publications - Michelle P. Lin, M.D., M.P.H. - Mayo Clinic

    Interleukin-1 receptor role in the viability of corneal myofibroblasts. Exp Eye Res. 2012 Mar; 96 (1):65-9 Epub 2012 Jan 10. View PubMed; Allan EJ, Flowers ME ...